FibroBiologics Ownership | Who Owns FibroBiologics?


OverviewRevenueFinancialsChart

FibroBiologics Ownership Summary


FibroBiologics is owned by 5.29% institutional investors, 15.93% insiders, and 78.78% retail investors. Vanguard group is the largest institutional shareholder, holding 3.19% of FBLG shares.

FBLG Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFibroBiologics5.29%15.93%78.78%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.23M3.19%$673.64K
Blackrock funding, inc. /de439.77K1.14%$240.20K
Landscape capital management350.00K0.91%$191.17K
Gts securities308.66K0.80%$168.53K
Cascade financial partners298.08K0.77%$162.81K
Geode capital management288.95K0.75%$157.91K
Cerity partners125.92K0.33%$68.78K
State street111.30K0.29%$60.79K
Optivise advisory services110.10K0.28%$60.14K
Requisite capital management109.71K0.28%$59.92K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Luminus management26.63K0.31%$345.77K
Optivise advisory services110.10K0.04%$60.14K
American institute for advanced investment management, llp88.21K0.03%$48.18K
Cascade financial partners298.08K0.02%$162.81K
Landscape capital management350.00K0.01%$191.17K
Requisite capital management109.71K0.01%$59.92K
Saxon interests21.21K0.01%$19.09K
Gts securities308.66K0.01%$168.53K
Runnymede capital advisors10.00K0.00%$5.46K
Rmr wealth builders38.36K0.00%$20.95K

Top Buyers

HolderShares% AssetsChange
Landscape capital management350.00K0.01%350.00K
Gts securities308.66K0.01%308.66K
Renaissance59.80K-59.80K
Wiley bros.-aintree capital100.00K0.00%30.00K
Luminus management26.63K0.31%26.63K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de439.77K--311.13K
Goldman sachs group10.47K--121.07K
Jane street group---96.11K
Marshall wace, llp---78.62K
Charles schwab investment management---69.81K

New Positions

HolderShares% AssetsChangeValue
Landscape capital management350.00K0.01%350.00K$191.17K
Gts securities308.66K0.01%308.66K$168.53K
Renaissance59.80K-59.80K$32.66K
Luminus management26.63K0.31%26.63K$345.77K
Global assets advisory10.70K0.00%10.70K$5.84K

Sold Out

HolderChange
Ifp advisors-1.00
Sterling capital management-26.00
Citigroup-171.00
Nisa investment advisors-196.00
Clearstead advisors-202.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202518-66.04%2,042,975-56.57%53.57%6-76.00%4-71.43%
Jun 30, 202556-13.85%5,105,357-20.53%134.31%27-18.18%1633.33%
Mar 31, 2025644.92%6,419,50319.66%176.83%326.67%1220.00%
Dec 31, 2024625.08%5,939,3658.81%176.68%31-11.43%1066.67%
Sep 30, 20245915.69%5,458,64321.42%168.63%35-23.91%650.00%

Recent Insider Transactions


DateNameRoleActivityValue
May 27, 2025Khoja Hamid Chief Scientific OfficerBuy$16.80K

Insider Transactions Trends


DateBuySell
2025 Q21-
2025 Q1--
2024 Q4--

FBLG Ownership FAQ


Who Owns FibroBiologics?

FibroBiologics shareholders are primarily institutional investors at 5.29%, followed by 15.93% insiders and 78.78% retail investors. The average institutional ownership in FibroBiologics's industry, Biotech Stocks , is 45.24%, which FibroBiologics falls below.

Who owns the most shares of FibroBiologics?

FibroBiologics’s largest shareholders are Vanguard group (1.23M shares, 3.19%), Blackrock funding, inc. /de (439.77K shares, 1.14%), and Landscape capital management (350K shares, 0.91%). Together, they hold 5.24% of FibroBiologics’s total shares outstanding.

Does Blackrock own FibroBiologics?

BlackRock is not among the top 10 institutional shareholders of FibroBiologics.

Who is FibroBiologics’s biggest shareholder by percentage of total assets invested?

Luminus management is FibroBiologics’s biggest shareholder by percentage of total assets invested, with 0.31% of its assets in 26.63K FibroBiologics shares, valued at 345.77K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools